基因组学市场中的区块链——全球产业规模、份额、趋势、机会和预测，按商业模式、服务、应用、最终用户、地区和竞争细分，2020-2030 年

2024 年全球基因组学区块链市场价值为 10.6 亿美元，预计在预测期内将实现强劲增长，到 2030 年的复合年增长率为 11.11%。区块链是一种数位公共分类账，可以安全地以区块为单位记录交易和资料。例如，2022 年，美国食品药物管理局 (FDA) 的药品评估和研究中心 (CDER) 批准了 37 个新分子实体 (NME)。在 35 种治疗性 NME 中，有 12 种（约 34%）被个人化医疗联盟 (PMC) 归类为个人化药物。这凸显了人们越来越重视根据个人基因、生物标记或分子图谱量身定制治疗，以改善治疗效果并减少不良反应。每个区块都带有时间戳记并连结到前一个区块，形成一条不可追溯的不可变链。这种去中心化框架允许资料在互连繫统网路中分发，而无需依赖中央权威，从而提高了透明度和可靠性。透过适当的授权实现全球可访问性，使用者可以控制自己的资料，确保隐私和安全。

关键市场驱动因素

私营企业和创投家的投资不断增加

主要市场挑战

监管挑战

主要市场趋势

技术创新

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球基因组学区块链市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依商业模式（B2B 商业模式、B2C 商业模式和 C2B 商业模式）
  • 按服务（实用代币和区块链平台）
  • 按应用（资料共享与货币化、资料储存与安全、自动化健康保险）
  • 按最终用户（製药和生物技术公司、医院和医疗保健提供者、研究机构、数据所有者等）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美基因组学区块链市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲基因组学区块链市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太地区基因组学区块链市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲基因组学区块链市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲基因组学区块链市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Oxford Nanopore Technologies Plc
• PacBio (Pacific Biosciences of California Inc.)
• Guardtime Ltd.
• Agilent Technologies Inc.
• Illumina Inc.
• BioRad Laboratories Inc.
• 10x Genomics Inc.
• QIAGEN NV
• Nebula Genomics Inc.
• Thermo Fisher Scientific

第 15 章：策略建议

第16章调查会社について・免责事项

Global Blockchain in Genomics Market was valued at USD 1.06 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 11.11% through 2030. Blockchain is a digital public ledger that securely records transactions and data in units known as blocks. For instane, in 2022, the FDA's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Of the 35 therapeutic NMEs, 12-around 34 percent-were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This highlights the growing emphasis on tailoring treatments based on individual genetic, biomarker, or molecular profiles to improve therapeutic outcomes and reduce adverse effects. Each block is timestamped and linked to the previous one, forming an immutable chain that cannot be altered retroactively. This decentralized framework allows data to be distributed across a network of interconnected systems without relying on a central authority, enhancing transparency and reliability. With global accessibility enabled through proper authorization, users maintain control over their data, ensuring privacy and security.

Key Market Drivers

Rising Investment by Private Players and Venture Capitalists

Increased investment provides researchers and innovators with the financial resources needed to explore and develop blockchain solutions tailored for genomics. This funding supports the creation of new platforms, tools, and applications that leverage blockchain's capabilities. For instance, in March 2024, MENADNA Inc., a prominent bioinformatics and genetic testing startup focused on the Middle East and North Africa (MENA) region, announced an exclusive partnership with Nebula Genomics, a leader in personalized genome sequencing. Under this agreement, MENADNA becomes Nebula's exclusive partner in Jordan, Oman, and Iraq. Currently active in the UAE, MENADNA also plans to expand into Saudi Arabia. The collaboration aims to enhance the region's representation in genomic research by combining Nebula's cutting-edge sequencing technology with MENADNA's proprietary bioinformatics platform, addressing a long-standing gap in global genome-wide association studies. Financial support from private players and venture capitalists accelerates the development of blockchain-based solutions for genomics. This leads to quicker advancements in technology, making blockchain more accessible and applicable to genomic research and data management. Funding supports the development of robust and scalable blockchain infrastructure required to handle large volumes of genomic data securely. This infrastructure enables efficient data storage, sharing, and analysis. Investments attract collaboration among stakeholders, including researchers, industry players, technology providers, and healthcare institutions. These partnerships foster a collaborative ecosystem that accelerates blockchain adoption in genomics. Venture capital investment fuels the growth of genomics-focused start-ups that are developing blockchain solutions. These start-ups contribute to the development of new platforms, tools, and applications, increasing the overall demand for blockchain technology. Investment in blockchain technology enables the streamlining of clinical trials, data sharing, and research collaboration. This leads to more efficient and cost-effective research efforts in genomics. Increasing investments from private players and venture capitalists are contributing to the growth of the Blockchain in Genomic Data Management Market. Recent developments in this field, such as strategic partnerships involving pharmaceutical companies and government bodies, as well as investments from venture capital and other stakeholders, indicate the growing acceptance of blockchain platforms for the storage and management of genetic information in the healthcare industry. These collective efforts will significantly drive the market's growth in the years to come.

Key Market Challenges

Regulatory Challenges

The use of blockchain technology in genomics presents several regulatory challenges that need to be addressed to ensure compliance with existing laws and ethical standards. These challenges stem from the unique nature of genomic data, data privacy concerns, data ownership, and the decentralized nature of blockchain. Genomic data is highly sensitive and personal. Regulatory frameworks, such as the General Data Protection Regulation (GDPR) in the European Union, require strict adherence to data privacy principles. Ensuring that individuals provide informed and explicit consent for their data to be stored, shared, and used on the blockchain is a significant challenge. Blockchain's decentralized nature challenges traditional concepts of data ownership. Determining who has control over genomic data stored on the blockchain and how individuals can assert their rights over their data is a regulatory hurdle. Integrating blockchain into existing regulatory frameworks designed for centralized systems can be difficult. Regulators must adapt or create new regulations that accommodate the unique characteristics of blockchain technology.

Key Market Trends

Innovations in Technology

Innovation in blockchain technology within the field of genomics has the potential to significantly boost its demand in the future by addressing existing challenges, enhancing data management, improving research collaboration, and enabling new possibilities for personalized medicine. Innovative blockchain solutions can offer even stronger data security and privacy features, assuaging concerns about the safe storage and sharing of sensitive genomic data. This can encourage more individuals to contribute their data for research and clinical purposes. Blockchain innovations can introduce advanced consent management and data ownership mechanisms. Individuals will have greater control over their genetic data, leading to increased willingness to participate in research initiatives. Innovative blockchain platforms can facilitate secure cross-border data sharing and collaboration among researchers and institutions. This can accelerate the pace of genomics research by allowing global participation and knowledge exchange. As blockchain technology continues to evolve and new innovations emerge, the demand for its integration in genomics is likely to grow. These innovations can address critical concerns, unlock new research opportunities, and ultimately lead to improved patient care, driving the adoption and utilization of blockchain technology in the field of genomics.

Key Market Player

• Oxford Nanopore Technologies Plc
• PacBio (Pacific Biosciences of California Inc.)
• Guardtime Ltd.
• Agilent Technologies Inc.
• Illumina Inc.
• BioRad Laboratories Inc.
• 10x Genomics Inc.
• QIAGEN NV
• Nebula Genomics Inc.
• Thermo Fisher Scientific.

Report Scope:

In this report, the Global Blockchain in Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blockchain in Genomics Market, By Business Model:

• B2B Business Model
• B2C Business Model
• C2B Business Model

Blockchain in Genomics Market, By Service:

• Utility Tokens
• Blockchain Platforms

Blockchain in Genomics Market, By Application:

• Data Sharing & Monetization
• Data Storage & Security
• Automated Health Insurance

Blockchain in Genomics Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Hospitals & Healthcare Providers
• Research Institutes
• Data Owners
• Others

Blockchain in Genomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blockchain in Genomics Market.

Available Customizations:

Global Blockchain in Genomics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blockchain in Genomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model)
  • 5.2.2. By Service (Utility Tokens and Blockchain Platforms)
  • 5.2.3. By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance)
  • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Research Institutes, Data Owners, And Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Blockchain in Genomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Business Model
  • 6.2.2. By Service
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blockchain in Genomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Business Model
      • 6.3.1.2.2. By Service
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Blockchain in Genomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Business Model
      • 6.3.2.2.2. By Service
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Blockchain in Genomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Business Model
      • 6.3.3.2.2. By Service
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Blockchain in Genomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Business Model
  • 7.2.2. By Service
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blockchain in Genomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Business Model
      • 7.3.1.2.2. By Service
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Blockchain in Genomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Business Model
      • 7.3.2.2.2. By Service
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Blockchain in Genomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Business Model
      • 7.3.3.2.2. By Service
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France Blockchain in Genomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Business Model
      • 7.3.4.2.2. By Service
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Blockchain in Genomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Business Model
      • 7.3.5.2.2. By Service
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Blockchain in Genomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Business Model
  • 8.2.2. By Service
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Blockchain in Genomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Business Model
      • 8.3.1.2.2. By Service
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Blockchain in Genomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Business Model
      • 8.3.2.2.2. By Service
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Blockchain in Genomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Business Model
      • 8.3.3.2.2. By Service
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Blockchain in Genomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Business Model
      • 8.3.4.2.2. By Service
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Blockchain in Genomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Business Model
      • 8.3.5.2.2. By Service
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Blockchain in Genomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Business Model
  • 9.2.2. By Service
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blockchain in Genomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Business Model
      • 9.3.1.2.2. By Service
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Blockchain in Genomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Business Model
      • 9.3.2.2.2. By Service
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Blockchain in Genomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Business Model
      • 9.3.3.2.2. By Service
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Blockchain in Genomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Business Model
  • 10.2.2. By Service
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blockchain in Genomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Business Model
      • 10.3.1.2.2. By Service
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Blockchain in Genomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Business Model
      • 10.3.2.2.2. By Service
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Blockchain in Genomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Business Model
      • 10.3.3.2.2. By Service
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Oxford Nanopore Technologies Plc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. PacBio (Pacific Biosciences of California Inc.)
• 14.3. Guardtime Ltd.
• 14.4. Agilent Technologies Inc.
• 14.5. Illumina Inc.
• 14.6. BioRad Laboratories Inc.
• 14.7. 10x Genomics Inc.
• 14.8. QIAGEN NV
• 14.9. Nebula Genomics Inc.
• 14.10. Thermo Fisher Scientific

15. Strategic Recommendations

16. About Us & Disclaimer